GGrantIndex
← Search

Chemical Synthesis and High-Throughput Analytics Shared Resource

$140,940P30FY2021CANIH

Vanderbilt University Medical Center, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

CORE 005 ? CHEMICAL SYNTHESIS AND HIGH-THROUGHPUT ANALYTICS SHARED RESOURCE PROJECT SUMMARY/ABSTRACT The Vanderbilt Chemical Synthesis and High-throughput Analytics Shared Resource (CSHTASR) provides state-of-the-art capabilities for the Vanderbilt-Ingram Cancer Center (VICC) research community, inclusive of our VICC members and partners at Meharry Medical College, Tennessee State University, and other NCI Cancer Centers. CSHTASR works to harness the power of chemistry and assay technologies to support research requiring the application or discovery of chemical tools to answer biological questions. Projects supported by this shared resource include: ? Medicinal chemistry; including hit optimization and hit-to-lead activities, as well as discovery of novel compounds for pre-clinical or hypothesis-driven in vitro studies ? Large-scale synthesis (10-100 grams) and compound formulation to support in vivo animal studies ? Synthesis of isotopically labeled compounds including metabolites for mass spectral quantification in clinical samples ? Synthesis and design of affinity and fluorescent probes ? Synthesis of natural and unnatural nucleotides and peptides ? High-throughput instrumentation that provides static and kinetic readouts for multiple assays including biochemical, cell-based, phenotypic, high-content image-based, 3D culture models, and whole organisms ? Functional genomic screens to identify novel drug targets and mechanism(s) of drug action/resistance ? Kinetic assays to support complex dynamic models ? ?Focused? compound/drug library screening and drug combinations ? e.g., FDA drug collection (1,300), anti-cancer set (>1,000), etc., for translational projects ? Full high-throughput screening campaigns of diverse, large (>350,000) compound libraries, which is coordinated with medicinal chemistry to discover new chemistry and novel compounds for disease- related targets. The CSHTASR provides these services through a combination of instrument technology and staff expertise. Institutional and NIH funds have been invested to acquire leading-edge instrumentation required for effective and efficient CSHTASR services. In addition, our compound and FGS libraries are valuable material resources that allow interrogation of biological activity, providing insight into target/pathway identification and starting points for chemical probe optimization. The CSHTASR employs a highly trained leadership and support staff with extensive experience and expertise in advanced chemistry techniques and HTS methodologies.

View original record on NIH RePORTER →